Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?

被引:22
作者
Linnemann, Birgit [1 ]
Schindewolf, Marc [1 ]
Zgouras, Dimitrios [1 ]
Erbe, Matthias [1 ]
Jarosch-Preusche, Marie [1 ]
Lindhoff-Last, Edelgard [1 ]
机构
[1] Univ Hosp Frankfurt, Dept Internal Med, Div Vasc Med, D-60570 Frankfurt, Germany
关键词
thrombophilia; arterial thrombosis; myocardial infarction; ischemic stroke; venous thromboembolism;
D O I
10.1016/j.thromres.2007.07.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Whether thrombophilic disorders, which are established risk factors for venous thromboembolism (VTE), also increase the risk of arterial thrombosis is still unknown. Materials and methods: We analyzed data from 1081 consecutive patients (649 F/432 M, 16-93 years of age) with previous VTE registered in the MAISTHRO (MAin-ISar-THROmbosis) database with regard to arterial thrombotic events and contributing risk factors. Screening for thrombophilia included testing for factor V Leiden and prothrombin G20210A mutation, antiphospholipid antibodies and activities of factor VIII, protein C, protein S and antithrombin. Results: Of the entire study cohort, 40 patients (3.7%) had a prior myocardial infarction (MI), and 41 (3.8%) suffered a stroke. Other arterial thrombotic events were rare. Elevated factor VIII levels were more prevalent in MI patients than in controls (44.4 vs. 25.9%, p=0.044), but after adjusting for the traditional cardiovascular risk factors, this relationship was no longer significant. We observed a higher rate of lupus anticoagulant in MI patients with an adjusted odds ratio of 3.3 (95%CI 0.84-12.8, p=0.090). No difference in any other tested thrombophilia was observed in patients with MI or stroke relative to those without. Conclusion: The cumulative incidence of arterial thrombotic events in VTE patients is low, and the inherited thrombophilias do not seem to substantially increase the risk of arterial thrombosis. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:743 / 750
页数:8
相关论文
共 41 条
[31]   International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) [J].
Miyakis, S ;
Lockshin, MD ;
Atsumi, T ;
Branch, DW ;
Brey, RL ;
Cervera, R ;
Derksen, RHWM ;
De Groot, PG ;
Koike, T ;
Meroni, PL ;
Reber, G ;
Shoenfeld, Y ;
Tincani, A ;
Vlachoyiannopoulos, PG ;
Krilis, SA .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (02) :295-306
[32]   Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of age [J].
Muntner, P ;
Garrett, E ;
Klag, MJ ;
Coresh, J .
STROKE, 2002, 33 (05) :1209-1213
[33]   The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins lupus cohort [J].
Petri, M .
THROMBOSIS RESEARCH, 2004, 114 (5-6) :593-595
[34]   Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis [J].
Prandoni, P. ;
Ghirarduzzi, A. ;
Prins, M. H. ;
Pengo, V. ;
Davidson, B. L. ;
Sorensen, H. ;
Pesavento, R. ;
Iotti, M. ;
Casiglia, E. . ;
Iliceto, S. ;
Pagnan, A. ;
Lensing, A. W. A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (09) :1891-1896
[35]  
Rice GI, 1998, THROMB HAEMOSTASIS, V80, P757
[36]   MUTATION IN THE GENE CODING FOR COAGULATION-FACTOR-V AND THE RISK OF MYOCARDIAL-INFARCTION, STROKE, AND VENOUS THROMBOSIS IN APPARENTLY HEALTHY-MEN [J].
RIDKER, PM ;
HENNEKENS, CH ;
LINDPAINTER, K ;
STAMPFER, MJ ;
EISENBERG, PR ;
MILETICH, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) :912-917
[37]   G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men [J].
Ridker, PM ;
Hennekens, CH ;
Miletich, JP .
CIRCULATION, 1999, 99 (08) :999-1004
[38]   Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women [J].
Rosendaal, FR ;
Siscovick, DS ;
Schwartz, SM ;
Beverly, RK ;
Psaty, BM ;
Longstreth, WT ;
Raghunathan, TE ;
Koepsell, TD ;
Reitsma, PH .
BLOOD, 1997, 89 (08) :2817-2821
[39]   High prevalence of thrombophilia among young patients with myocardial infarction and few conventional risk factors [J].
Segev, A ;
Ellis, MH ;
Segev, F ;
Friedman, Z ;
Reshef, T ;
Sparkes, JD ;
Tetro, J ;
Pauzner, H ;
David, D .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 98 (03) :421-424
[40]   No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease - Results from the cardiovascular health study [J].
Smiles, AM ;
Jenny, NS ;
Tang, ZH ;
Arnold, A ;
Cushman, M ;
Tracy, RP .
THROMBOSIS AND HAEMOSTASIS, 2002, 87 (04) :614-621